T cell compositions
US11479755B2 · kind B2 · utility
4Cited by
38References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 7, 2015 |
| Grant date | Oct 25, 2022 |
| Priority date | — |
| Expiry date | Oct 9, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16043
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides improved T cell compositions and methods for manufacturing T cells. More particularly, the invention provides methods of T cell manufacturing that result in adoptive T cell immunotherapies with improved survival, expansion, and persistence in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.